Drug Type CAR-T |
Synonyms EpCAM and ICAM-1 dual CAR-T (AffyImmune Therapeutics) |
Target |
Mechanism EpCAM inhibitors(Epithelial cell adhesion molecule inhibitors), ICAM-1 inhibitors(Intercellular adhesion molecule-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 09 Oct 2021 |